{"id":446338,"title":"Consultation: Adding melatonin for sleep-related use in the pediatric population to the Prescription Drug List - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T11:40:52.621000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/programs/consultation-adding-melatonin-sleep-related-use-pediatric-population-prescription-drug-list.html?wbdisable=false","snippet":"Consultation: Adding melatonin for sleep-related use in the pediatric population to the Prescription Drug List Current status: Open Opened on September 16, 2025 and will close to new input on December 30, 2025. The purpose of this consultation is to communicate to industry,…","rawSnapshotUrl":"/api/snapshots/raw/446338","browseUrl":"https://replay.healtharchive.ca/job-6/20260103114052/https://www.canada.ca/en/health-canada/programs/consultation-adding-melatonin-sleep-related-use-pediatric-population-prescription-drug-list.html?wbdisable=false#ha_snapshot=446338","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}